ArticleBrain : a journal of neurology2023

Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial.

Raphael Schiffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.